Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.
Loading...
Embargo End Date
ICR Authors
Authors
Chakraborty, R
Cheruvalath, H
Patwari, A
Szabo, A
Schinke, C
Dhakal, B
Lentzsch, S
D'Souza, A
Mohyuddin, GR
Julian, K
Midha, S
Costello, P
Kaiser, M
Hing, MNL
Harrison, SJ
Cliff, ERS
Mohan, M
Cheruvalath, H
Patwari, A
Szabo, A
Schinke, C
Dhakal, B
Lentzsch, S
D'Souza, A
Mohyuddin, GR
Julian, K
Midha, S
Costello, P
Kaiser, M
Hing, MNL
Harrison, SJ
Cliff, ERS
Mohan, M
Document Type
Journal Article
Date
2024-08-12
Date Accepted
2024-07-26
Abstract
Citation
Blood Cancer Journal, 2024, 14 (1), pp. 137 -
Source Title
Blood Cancer Journal
Publisher
SPRINGERNATURE
ISSN
2044-5385
eISSN
2044-5385
Collections
Research Team
Myeloma Molecular Therapy